Anti-CD44 monoclonal antibody KM81

Drug Profile

Anti-CD44 monoclonal antibody KM81

Alternative Names: KM81

Latest Information Update: 26 Aug 2002

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Nonindustrial source
  • Class Antineoplastics; Antirheumatics; Monoclonal antibodies
  • Mechanism of Action CD44 antigen inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Graft-versus-host disease; Rheumatoid arthritis

Most Recent Events

  • 18 Aug 1998 No-Development-Reported for Graft-versus-host disease in USA (Unknown route)
  • 31 Jul 1997 Preclinical development for Rheumatoid arthritis in USA (Unknown route)
  • 31 Mar 1994 Preclinical development for Graft-versus-host disease in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top